| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/23/2002 | US6376240 Nucleic acid has a nucleotide sequence encoding rflat-1, a zinc finger transcription factor; expression cassette |
| 04/23/2002 | US6376236 Alphavirus vector construct which directs the expression of a heterologous nucleic acid molecule; capsid protein; and envelope glycoprotein from a second virus different from the alphavirus of said alphavirus vector construct |
| 04/23/2002 | US6376224 Composition comprising inhibitor for membrane pumps and photoaffinity-labeled chemotherapeutic agent |
| 04/23/2002 | US6376217 Fusion protein comprising gelonin amino acid sequence having enzymatic activity and antibody, antigen-binding fragment, hormone, lymphokine or growth factor targeting sequence allowing internalization of fusion protein |
| 04/23/2002 | US6376214 DNA encoding a novel homolog of CSBP/p38 MAP kinase |
| 04/23/2002 | US6376198 Screening with enhanced chimeric g protein-coupled peptide hormone receptor that signals through wild-type pathway, in which region of functional domain of one peptide hormone receptor is replaced with corresponding region of another |
| 04/23/2002 | US6376196 Contacting sample with isolated immunodominant neospora antigen, thereby forming antigen/antibody complex and detecting presence of antibodies specifically immunoreactive with bovine neospora antigen |
| 04/23/2002 | US6376174 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto |
| 04/23/2002 | US6375989 Submucosa extracts |
| 04/23/2002 | US6375985 System and method for producing drug-loaded microparticles |
| 04/23/2002 | US6375975 Pharmaceutical compositions for buccal and pulmonary application |
| 04/23/2002 | US6375955 Peptides |
| 04/23/2002 | US6375953 Treatment of infectious diseases with HSP70-peptide complexes |
| 04/23/2002 | US6375952 Isolated herpes simplex virus polypeptide |
| 04/23/2002 | US6375950 Methods for inducing T cell unresponsiveness to donor tissue or organ in a recipient with gp39 antagonists |
| 04/23/2002 | US6375948 Treating method for suppressing hair growth |
| 04/23/2002 | US6375947 Recombinant kid pregastric esterase and methods for its production and use |
| 04/23/2002 | US6375946 Antitumor, viricides,nk cell activating cytokine or a nk cell activating flavonoid and a compound effective to inhibit the production or release of hydrogen peroxide selected from the group consisting of histamine, other h.sub.2 receptor |
| 04/23/2002 | US6375944 Methods and compositions for enhancing the immunostimulatory effect of interleukin-12 |
| 04/23/2002 | US6375942 Petrolatum, wax, antibiotic, zinc oxide and anit-itch |
| 04/23/2002 | US6375929 Gene therapy for inhibition of angiogenesis |
| 04/23/2002 | US6375928 Neutrophil stimulating peptides |
| 04/23/2002 | CA2300386C Method for treating dystonia with botulinum toxin types c,d and e |
| 04/23/2002 | CA2191714C Therapeutic food composition and method to diminish blood sugar fluctuations |
| 04/23/2002 | CA2166312C Compositions for nasal administration of desmopressin |
| 04/23/2002 | CA2004127C Novel aminobenzoates |
| 04/18/2002 | WO2002031512A2 Molecular interactions in hematopoietic cells |
| 04/18/2002 | WO2002031499A1 Detection of neurodegenerative disorders |
| 04/18/2002 | WO2002031498A2 Protecting therapeutic compositions from host-mediated inactivation |
| 04/18/2002 | WO2002031208A1 Method for identifying type 2 hypercarbic respiratory failure associated with community acquired pneumonia |
| 04/18/2002 | WO2002031198A2 Cancer-linked genes as targets for chemotherapy |
| 04/18/2002 | WO2002031180A2 Flea peritrophin nucleic acid molecules, proteins and uses thereof |
| 04/18/2002 | WO2002031163A1 Novel adamts family polypeptide and gene encoding the same |
| 04/18/2002 | WO2002031162A2 Regulation of human phospholipase a2-like enzyme |
| 04/18/2002 | WO2002031161A2 Regulation of human phospholipase-like enzyme |
| 04/18/2002 | WO2002031160A2 Regulation of human phospholipase a2-like enzyme |
| 04/18/2002 | WO2002031156A2 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 04/18/2002 | WO2002031152A2 Intracellular signaling molecules |
| 04/18/2002 | WO2002031151A2 Lipocalins |
| 04/18/2002 | WO2002031149A2 Polyvalent cation-sensing receptor proteins in aquatic species |
| 04/18/2002 | WO2002031146A2 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 04/18/2002 | WO2002031145A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/18/2002 | WO2002031144A2 Identification of cytotoxic activity from the ink of aplysia punctata |
| 04/18/2002 | WO2002031143A2 Nucleic acid sequences encoding cmg proteins cmg proteins and methods for their use |
| 04/18/2002 | WO2002031142A2 Antisense nucleic acid against alphav integrin |
| 04/18/2002 | WO2002031141A2 Antisense oligonucleotide directed toward mammalian vegf receptor genes and uses thereof |
| 04/18/2002 | WO2002031138A1 Paramyxovirus vector for transferring foreign gene into skeletal muscle |
| 04/18/2002 | WO2002031128A1 Methods of agonizing and antagonizing fabk |
| 04/18/2002 | WO2002031126A2 Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase |
| 04/18/2002 | WO2002031125A2 Human phospholipase a2-like enzyme |
| 04/18/2002 | WO2002031117A2 Clasp-2 transmembrane proteins |
| 04/18/2002 | WO2002031116A2 Gene expression modulated in spontaneous inflammatory bowel disease |
| 04/18/2002 | WO2002031115A2 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | WO2002031114A2 Gene expression modulated in ileitis |
| 04/18/2002 | WO2002031110A2 Hematopoietic stem cell gene therapy |
| 04/18/2002 | WO2002031109A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | WO2002031025A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 04/18/2002 | WO2002030983A2 Plasma fraction containing bikunin, method for the production thereof and use of the same |
| 04/18/2002 | WO2002030982A2 Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use |
| 04/18/2002 | WO2002030980A2 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 04/18/2002 | WO2002030979A2 Polypeptides homologous to thymosin, ephrin a receptors, and fibromodulin, and polynucleotides encoding same |
| 04/18/2002 | WO2002030978A1 Polypeptides, methods of making, and uses thereof |
| 04/18/2002 | WO2002030976A1 Cell control nucleic acids and proteins |
| 04/18/2002 | WO2002030975A2 Antifungal peptides |
| 04/18/2002 | WO2002030972A2 Regulation of nf-at interacting protein nip 45 like protein |
| 04/18/2002 | WO2002030970A2 Human histone deacetylase gene |
| 04/18/2002 | WO2002030969A2 Regulation of human carboxylesterase-like enzyme |
| 04/18/2002 | WO2002030968A1 Novel mite allergens and uses therefor |
| 04/18/2002 | WO2002030957A1 Peptide-based gemini surfactant compounds facilitating the transfer into cells |
| 04/18/2002 | WO2002030956A1 N-alkylglycine trimeres capable of blocking the response to chemical substances, heat stimuli or mediators of neuronal receptor inflammation and compositions containing said trimeres |
| 04/18/2002 | WO2002030955A2 Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use |
| 04/18/2002 | WO2002030922A2 Dioxolane analogs for improved inter-cellular delivery |
| 04/18/2002 | WO2002030889A2 A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury |
| 04/18/2002 | WO2002030887A2 Protein having thrombolytic activities extracted from natural product |
| 04/18/2002 | WO2002030873A1 Mmp inhibitor |
| 04/18/2002 | WO2002030470A1 Methods and compositions for nucleic acid delivery |
| 04/18/2002 | WO2002030468A1 Complexes for transferring nucleic acids into cells |
| 04/18/2002 | WO2002030465A2 Compositions that inhibit proliferation of cancer cells |
| 04/18/2002 | WO2002030464A1 Novel drugs for liver diseases |
| 04/18/2002 | WO2002030463A2 Reduced-viscosity concentrated protein formulations |
| 04/18/2002 | WO2002030462A2 Hedgehog antagonists, methods and uses related thereto |
| 04/18/2002 | WO2002030455A2 Agents for the treatment of viral infections |
| 04/18/2002 | WO2002030454A1 Methods for controlling the lysis of coagulated blood with apolipoprotein e4 phenotype |
| 04/18/2002 | WO2002030453A1 Methods of inhibiting angiogenesis using nadph oxidase inhibitors |
| 04/18/2002 | WO2002030451A1 Compositions and methods for reducing gnrh-induced bone loss |
| 04/18/2002 | WO2002030450A1 Use of d-leu deltorphin for protection against ischemia and reperfusion injury |
| 04/18/2002 | WO2002030448A2 Treatment of demyelinating diseases by administering gpe |
| 04/18/2002 | WO2002030447A2 Treatment of demyelinating diseases by administering gpe |
| 04/18/2002 | WO2002030446A2 Reduction or prevention of post-surgical adhesion formation with fibrinogen |
| 04/18/2002 | WO2002030445A2 Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation |
| 04/18/2002 | WO2002030444A2 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 04/18/2002 | WO2002030443A2 Regulation of human skin healing |
| 04/18/2002 | WO2002030442A2 Use of [d-leu2]-deltrophin for treating cytokine mediated hgepatic injury |
| 04/18/2002 | WO2002030441A2 Treatment of cancers by aplidine in conjunction with a myoprotector |
| 04/18/2002 | WO2002030435A1 Treatment of t cell disorders |
| 04/18/2002 | WO2002030434A1 Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins |
| 04/18/2002 | WO2002030421A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/18/2002 | WO2002030396A1 Medication delivery devices |
| 04/18/2002 | WO2002030393A2 Polymeric delivery formulations of leuprolide with improved efficacy |
| 04/18/2002 | WO2002030371A1 Dyeing composition promoting natural pigmentation, method for obtaining same and use for colouring the skin and/or keratinous fibres |